0910-AA01 200304 Unified Agenda of Federal Regulatory and Deregulatory Actions 0910 Food and Drug Administration FDA 0900 Department of Health and Human Services HHS Over-the-Counter (OTC) Drug Review Routine and Frequent Previously Published in The Unified Agenda Prerule Stage No No 21 CFR 201 21 CFR 310 21 CFR 330 to 350 21 USC 321p 21 USC 351 to 353 21 USC 355 21 USC 360a 21 USC 371a 21 USC 331 21 USC 360 21 USC 360b 21 USC 361 21 USC 371 No 0910-AC65 Anorectal Products 0910-AC71 Antiemetic Products 0910-AC89 Antiperspirant Products 0910-AD31 Cough/Cold (Antihistamine) Products 0910-AD24 Cough/Cold (Antitussive) Products 0910-AD25 Cough/Cold (Combination) Products 0910-AD43 Cough/Cold (Nasal Decongestant) Products 0910-AD06 External Analgesic Products 0910-AD21 Ingrown Toenail Relief Products 0910-AD07 Internal Analgesic Products 0910-AD47 Labeling of Drug Products for OTC Human Use 0910-AD11 Nighttime Sleep Aid Products 0910-AC72 Ophthalmic Products 0910-AC98 Oral Health Care Products 0910-AC79 Pediculicide Products 0910-AD13 Salicylate (Reye's Syndrome) 0910-AC68 Sunscreen Products 0910-AD19 Vaginal Contraceptive Products 0910-AC93 Weight Control Products 0910-AC85 Laxative Drug Products 0910-AC82 Antidiarrheal Products 0910-AD33 Cough/Cold (Bronchodilator) Products 0910-AC96 Skin Protectant Products Yes Businesses None No NA Not Collected Gerald Rachanow M. 0910 Food and Drug Administration FDA 301 827-2241 301 827-2315 gerald.rachanow@fda.hhs.gov HFD-560, Center for Drug Evaluation and Research (HFD-560), 5600 Fishers Lane, Rockville MD 20857